GlassScriptPhysician profile
Hank Ng
NPI 1790179745
$8,981.78
in general payments reported to CMS, 2019-2025
40 companies · $2,405 in 2025
The $2,405 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $99.00 · 2021: $974 · 2022: $1,050 · 2023: $4,250 · 2025: $2,405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,082 · Consulting Fee: $2,010 · Honoraria: $1,500 · Food and Beverage: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,081.53 |
| Consulting Fee | $2,010.00 |
| Honoraria | $1,500.00 |
| Food and Beverage | $1,063.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $4,033.87 | 2023 | Monoferric |
| Astrazeneca Pharmaceuticals LP | $2,166.13 | 2021-2025 | Lynparza, Imfinzi, Enhertu |
| Pfizer INC. | $296.45 | 2021-2025 | |
| Seagen INC. | $239.81 | 2020-2022 | |
| Eisai INC. | $208.85 | 2019-2025 | |
| Janssen Biotech, INC. | $200.59 | 2021-2025 | Darzalex |
| Genzyme Corporation | $186.62 | 2021-2022 | |
| Incyte Corporation | $171.56 | 2019-2022 | |
| Lilly USA, LLC | $163.09 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $127.31 | 2021 | |
| Genentech USA, INC. | $110.33 | 2021-2025 | Polivy |
| Regeneron Healthcare Solutions, INC. | $79.33 | 2021-2022 | |
| Pharmacyclics LLC, An Abbvie Company | $66.52 | 2021-2022 | |
| Ge Healthcare | $65.48 | 2022 | |
| Glaxosmithkline, LLC. | $65.38 | 2021-2023 | Ojjaara |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hank Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.